SIM
ABBV icon

Sonora Investment Management’s AbbVie ABBV Stock Holding History

Sonora Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$708K Buy
6,562
+1,134
+21% +$130K 0.09% 114
2021
Q2 		$611K Buy
5,428
+393
+8% +$44.3K 0.08% 116
2021
Q1 		$545K Sell
5,035
-1,049
-17% -$112K 0.04% 206
2020
Q4 		$652K Sell
6,084
-11
-0.2% -$1.06K 0.05% 191
2020
Q3 		$534K Buy
6,095
+3,219
+112% +$303K 0.05% 194
2020
Q2 		$282K Buy
2,876
+250
+10% +$22K 0.03% 223
2020
Q1 		$200K Buy
2,626
+510
+24% +$43.4K 0.02% 229
2019
Q4 		$187K Buy
2,116
+10
+0.5% +$830 0.02% 255
2019
Q3 		$159K Sell
2,106
-236
-10% -$16.2K 0.02% 264
2019
Q2 		$170K Buy
2,342
+267
+13% +$21K 0.02% 255
2019
Q1 		$167K Buy
2,075
+473
+30% +$38.7K 0.02% 243
2018
Q4 		$148K Buy
1,602
+150
+10% +$13.2K 0.02% 242
2018
Q3 		$137K Hold
1,452
– – 0.02% 250
2018
Q2 		$135K Sell
1,452
-837
-37% -$81.7K 0.02% 238
2018
Q1 		$217K Buy
2,289
+37
+2% +$4.07K 0.03% 194
2017
Q4 		$218K Buy
2,252
+384
+21% +$36.2K 0.04% 194
2017
Q3 		$166K Buy
1,868
+248
+15% +$18.9K 0.03% 202
2017
Q2 		$117K Hold
1,620
– – 0.02% 234
2017
Q1 		$106K Sell
1,620
-100
-6% -$6.29K 0.02% 241
2016
Q4 		$108K Hold
1,720
– – 0.02% 211
2016
Q3 		$108K Buy
1,720
+1,257
+271% +$81.4K 0.02% 211
2016
Q2 		$28.7K Buy
463
+112
+32% +$6.83K 0.01% 340
2016
Q1 		$21.4K Sell
351
-103
-23% -$5.74K 0.01% 470
2015
Q4 		$27K Sell
454
-225
-33% -$13K 0.01% 329
2015
Q3 		$41K Buy
+679
New +$44.2K 0.01% 235

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sonora Investment Management's ABBV Position: Q3 2021 in Review

Sonora Investment Management increased its AbbVie (ABBV) stake by 21% in Q3 2021, buying an estimated $130K and bringing the position to 6,562 shares worth $708K. The position accounts for 0.09% of the portfolio, ranked #114.

Sonora Investment Management first reported a position in ABBV in Q3 2015 and has held it in 25 quarters since. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Sonora Investment Management held 6,562 shares of AbbVie worth $708K as of Q3 2021.
  • Sonora Investment Management bought 1,134 AbbVie shares in Q3 2021, an estimated $130K.
  • AbbVie made up 0.09% of Sonora Investment Management's portfolio in Q3 2021, its #114 holding.
  • Sonora Investment Management first reported a position in AbbVie in Q3 2015 and has held it in 25 quarters since.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Sonora Investment Management's 13F filing for Q3 2021, filed 12 Nov 2021.